Danforth Advisors LLC, today announced the acquisition of PharmaDirections, Inc., a full-spectrum development partner to life science companies, expanding its integrated capabilities from discovery through commercialization. Founded in 2003, PharmaDirections was a pioneer of the virtual drug development model. The company brings veteran program leaders and more than 150 specialists to support strategic planning and …

A study published this month in The BMJ (British Medical Journal) analyzed the use of optical sensor technology from ivWatch, the U.S.-based IV safety company, in the early detection of peripheral intravenous infiltration or extravasation (PIVIE) events in neonates. Presenting a comparative evaluation between conventional observational methods and continuous sensor-based monitoring, the study offers insights …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to RLS-0071 (pegtarazimod) for the treatment of Graft-versus-Host Disease (GvHD). The Orphan Drug Designation …

In a transformative move to accelerate global access to life-restoring technologies, LifeNet Health, a world leader in regenerative medicine, has acquired HCM Medical, a Netherlands-based contract manufacturing organization (CMO) known for its pioneering biologics and tissue-processing capabilities. This strategic acquisition addresses a critical challenge in modern healthcare: ensuring timely, equitable access to breakthrough regenerative therapies for …

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new Chief Financial Officer as the Company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization. Quoin has appointed Sally Lawlor, …

August 13, 2025  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.4 million in grants to three life and bioscience projects in the Commonwealth of Virginia through a highly-competitive Grant Round 18.   “The bioscience ecosystem in Virginia is vibrant, with university researchers, …

Governor Youngkin announces new Lab-to-Launch initiative to unlock innovation in Virginia by accelerating university research commercialization and technology transfer. Developed through a bold statewide collaboration between Virginia Innovation Partnership Corporation (VIPC) and Virginia’s six R1 research university partners – George Mason University, Old Dominion University, the University of Virginia, Virginia Commonwealth University, Virginia Tech, William …

CvilleBioHub will expand the Commonwealth BioAccelerator and state-of-the-art facilities at the North Fork Discovery Park. The expansion is powered by a transformational $15 million investment from the Commonwealth of Virginia and the University of Virginia. This funding establishes a commitment to life sciences entrepreneurship and commercialization in Virginia and signals a major leap forward for …

Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation award by the Medical CBRN Defense Consortium (MCDC) in recognition of its successful prototype development of the Rapid Opioid Countermeasure System (ROCS) (Naloxone HCl Injection, USP) antidote for ultra-potent weaponized opioids. This is the first time the …

For the third consecutive year, the BioHealth Capital Region (BHCR), encompassing Maryland, Virginia, and Washington, D.C., has earned a Top 3 position in the highly regarded “Top 10 U.S. Biopharma Clusters” list by Genetic Engineering & Biotechnology News (GEN). Compiled annually by GEN Senior Business Editor Alex Philippidis, this national ranking evaluates five key indicators …

Roanoke College and Virginia Western Community College are joining together to begin a new biotechnology bachelor’s degree program, according to officials. The program is expected to begin this fall. Officials say the development of the four-year program is a direct response to the region’s need for a strategic workforce that can help elevate the Roanoke …

RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). With the execution, this option funding will …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced the publication of an article in the American Journal of Perinatology showing the ability of RLS-0071 (pegtarazimod) to reduce key measures of brain inflammation in …

InBio, a global leader in high-quality, purified allergen proteins, and Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, are collaborating to enhance the performance of basophil activation tests (BAT) for food allergy research. The collaboration integrates InBio’s Food Protein Standards and purified allergens with the Next-Generation Basophil …

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased valuation from previous funding. The $37 million raise supports the Company’s mission of helping brilliant minds bring medicines to life through advanced development and manufacturing in America. The growing …

AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America and …

A team at the University of Virginia (UVA Health) led by Daniel Sheeran, MD, associate professor of radiology and medical imaging, has begun treating patients using HistoSonics’ Edison histotripsy system for liver tumors. The treatments are the first clinical histotripsy procedures in the state. Histotripsy noninvasively destroys tissue in the liver by using focused ultrasound to …

DPR Construction, one of the nation’s top technical builders, was named one of its Best Companies to Work For: Private Companies and one of the Best Companies to Work For: Engineering and Construction for the second consecutive year by U.S. News & World Report, the global authority in rankings and consumer advice. “DPR has been …

Manassas, Virginia – July 16, 2025 Thanks to a major investment from GO Virginia, the region’s first Innovation District is taking shape, laying the groundwork for growth in high-tech industry sectors like life sciences, aerospace, defense, and semiconductors. Governor Glenn Youngkin announced that the Commonwealth will invest $2.6 million in the effort, with an additional …

RIVANNA®, developers of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and SpineNav-AI™ image processing software. This clearance authorizes the use of both technologies in United States hospital and clinical settings, providing anatomical guidance during needle or …

Cupron Performance Additives (Cupron) today announced the launch of Cupron Clear™ — a revolutionary new liquid microbial copper platform. Cupron Clear™ is a transparent, stable, and highly efficacious liquid form of copper, designed for broad use across polymers and liquids. This new breakthrough delivers unmatched microbial control while exceeding modern standards for sustainability, economics, and …

CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, announced the closing of its best-efforts offering of 1,500,000 shares of its common stock. Each share of common stock was sold at an offering price of $3.82 per share, priced at-the-market under NYSE American rules. Total gross proceeds from the …

Civica announced the appointment of Dave Sehgal, Ph.D. as its new Chief Manufacturing Officer and Supply Chain Officer, effective July 21. In this role, Dr. Sehgal will lead Civica’s manufacturing strategy and operations, reporting directly to Ned McCoy, President and CEO. “We are excited to welcome Dave to our leadership team,” said McCoy. “His deep …

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with …